HXBM
Price
$7.18
Change
-$0.01 (-0.14%)
Updated
Mar 5 closing price
Capitalization
1.61M
INTI
Price
$0.06
Change
+$0.01 (+20.00%)
Updated
Apr 1 closing price
Capitalization
8.87M
Ad is loading...

HXBM vs INTI

Header iconHXBM vs INTI Comparison
Open Charts HXBM vs INTIBanner chart's image
Helix BioMedix
Price$7.18
Change-$0.01 (-0.14%)
Volume$100
Capitalization1.61M
Inhibitor Therapeutics
Price$0.06
Change+$0.01 (+20.00%)
Volume$167K
Capitalization8.87M
HXBM vs INTI Comparison Chart
Loading...
View a ticker or compare two or three
VS
HXBM vs. INTI commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HXBM is a Hold and INTI is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (HXBM: $7.18 vs. INTI: $0.05)
Brand notoriety: HXBM and INTI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HXBM: 79% vs. INTI: 3%
Market capitalization -- HXBM: $1.61M vs. INTI: $8.87M
HXBM [@Biotechnology] is valued at $1.61M. INTI’s [@Biotechnology] market capitalization is $8.87M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HXBM’s FA Score shows that 1 FA rating(s) are green whileINTI’s FA Score has 0 green FA rating(s).

  • HXBM’s FA Score: 1 green, 4 red.
  • INTI’s FA Score: 0 green, 5 red.
According to our system of comparison, HXBM is a better buy in the long-term than INTI.

Price Growth

HXBM (@Biotechnology) experienced а 0.00% price change this week, while INTI (@Biotechnology) price change was -14.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.91%. For the same industry, the average monthly price growth was -11.19%, and the average quarterly price growth was -14.86%.

Reported Earning Dates

INTI is expected to report earnings on Feb 20, 2025.

Industries' Descriptions

@Biotechnology (-8.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
INTI($8.87M) has a higher market cap than HXBM($1.61M). INTI YTD gains are higher at: -0.166 vs. HXBM (-10.250).
HXBMINTIHXBM / INTI
Capitalization1.61M8.87M18%
EBITDAN/A-3.07M-
Gain YTD-10.250-0.1666,160%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A6.38M-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
HXBM vs INTI: Fundamental Ratings
HXBM
INTI
OUTLOOK RATING
1..100
2794
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
8577
P/E GROWTH RATING
1..100
10086
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HXBM's Valuation (5) in the null industry is somewhat better than the same rating for INTI (58). This means that HXBM’s stock grew somewhat faster than INTI’s over the last 12 months.

HXBM's Profit vs Risk Rating (100) in the null industry is in the same range as INTI (100). This means that HXBM’s stock grew similarly to INTI’s over the last 12 months.

INTI's SMR Rating (98) in the null industry is in the same range as HXBM (99). This means that INTI’s stock grew similarly to HXBM’s over the last 12 months.

INTI's Price Growth Rating (77) in the null industry is in the same range as HXBM (85). This means that INTI’s stock grew similarly to HXBM’s over the last 12 months.

INTI's P/E Growth Rating (86) in the null industry is in the same range as HXBM (100). This means that INTI’s stock grew similarly to HXBM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DGRS47.270.54
+1.16%
WisdomTree US SmallCap Qual Div Gr ETF
BTA9.830.03
+0.31%
Blackrock Long-Term Municipal Advantage Trust
ILF23.960.07
+0.29%
iShares Latin America 40 ETF
CADHKD5.44N/A
N/A
Canadian Dollar - Hong Kong Dollar
EUO32.06-0.40
-1.24%
ProShares UltraShort Euro

HXBM and

Correlation & Price change

A.I.dvisor indicates that over the last year, HXBM has been loosely correlated with DWTX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if HXBM jumps, then DWTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HXBM
1D Price
Change %
HXBM100%
N/A
DWTX - HXBM
42%
Loosely correlated
-17.68%
NCNA - HXBM
25%
Poorly correlated
+1.13%
APVO - HXBM
23%
Poorly correlated
+38.26%
INRLF - HXBM
2%
Poorly correlated
N/A
INTI - HXBM
2%
Poorly correlated
N/A
More

INTI and

Correlation & Price change

A.I.dvisor tells us that INTI and QRON have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that INTI and QRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INTI
1D Price
Change %
INTI100%
N/A
QRON - INTI
24%
Poorly correlated
N/A
DWTX - INTI
23%
Poorly correlated
-17.68%
IVEVF - INTI
17%
Poorly correlated
N/A
IVBXF - INTI
11%
Poorly correlated
N/A
HSTC - INTI
8%
Poorly correlated
N/A
More